XLS — Xlife Sciences AG Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣120.54m
- CH₣268.05m
- CH₣0.83m
- 38
- 56
- 45
- 40
Annual cashflow statement for Xlife Sciences AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 21.1 | 53.3 | 8.78 | 9.27 | 28.7 |
| Depreciation | |||||
| Non-Cash Items | -20.9 | -48.3 | -28.2 | -20.4 | -42.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.635 | -9.41 | -1.25 | -4.72 | -3.12 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.402 | -4.32 | -4.61 | 0.172 | -0.422 |
| Capital Expenditures | -0.222 | -1.21 | -0.08 | -0.041 | -0.012 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -3.64 | -5.82 | -1.6 | -0.973 | -3.99 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3.86 | -7.03 | -1.68 | -1.01 | -4 |
| Financing Cash Flow Items | -0.573 | -0.73 | -0.347 | -0.01 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.43 | 8.6 | 4.56 | 0.829 | 4.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.16 | -2.75 | -1.74 | -0.002 | -0.12 |